Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Faeth Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q3 2022
- Shares held
- 2.64M
- −243.6K (−8.4%) vs. Q3 2022
- Total value
- $3.93M
- −$533.3K (−11.9%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 7
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Newtyn Management, LLC | 1,155,561 | $1.72M | 0.36% | +740,561+178.4% | Added |
| Vanguard Group Inc | 573,651 | $854.7K | 0.00% | +1950.0% | Added |
| Renaissance Technologies LLC | 172,554 | $257.0K | 0.00% | −33,246−16.2% | Reduced |
| Bridgeway Capital Management, LLC | 112,900 | $168.2K | 0.00% | −50,000−30.7% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $149.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 98,006 | $146.0K | 0.00% | +6,111+6.6% | Added |
| Millennium Management LLC | 67,242 | $100.0K | 0.00% | −11,839−15.0% | Reduced |
| Bank of America Corp | 48,681 | $72.5K | 0.00% | +11,775+31.9% | Added |
| Western Standard LLC | 46,117 | $68.7K | 0.06% | +46,117 | New |
| BlackRock Inc. | 36,873 | $54.9K | 0.00% | −137,077−78.8% | Reduced |
| Two Sigma Advisers, LP | 35,400 | $52.7K | 0.00% | −2,500−6.6% | Reduced |
| Ergoteles LLC | 34,340 | $51.2K | 0.00% | −55,627−61.8% | Reduced |
| Two Sigma Investments, LP | 31,076 | $46.3K | 0.00% | −4,700−13.1% | Reduced |
| Virtu Financial LLC | 26,060 | $39.0K | 0.01% | +26,060 | New |
| Northern Trust Corp | 26,049 | $38.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 25,774 | $38.4K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 19,000 | $28.3K | 0.00% | 00.0% | Unchanged |
| Deuterium Capital Management, LLC | 11,900 | $17.7K | 0.05% | +11,900 | New |
| Dimensional Fund Advisors LP | 11,570 | $17.0K | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 3,900 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,110 | $3.00K | 0.00% | −2,727−56.4% | Reduced |
| UBS Group AG | 1,097 | $1.64K | 0.00% | −12,017−91.6% | Reduced |
| JPMorgan Chase & Co | 668 | $1.00K | 0.00% | −1,045−61.0% | Reduced |
| Morgan Stanley | 249 | $371 | 0.00% | −13,320−98.2% | Reduced |
| Wells Fargo & Company | 123 | $183 | 0.00% | +3+2.5% | Added |
| Fiduciary Alliance LLC | 50 | $75 | 0.00% | +50 | New |
| Harbour Investments, Inc. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | −73−94.8% | Reduced |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −683,529−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −50,229−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,711−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,446−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −361−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −603−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −288−100.0% | Sold out |